{"count": 16, "results": [{"_id": "2442561", "pmid": 2442561, "title": "The safety and tolerability of lisinopril in clinical trials.", "journal": "J Cardiovasc Pharmacol", "authors": ["Rush JE", "Merrill DD"], "date": "1987-01-01T00:00:00Z", "doi": "10.1097/00005344-198700003-00023", "meta_date_publication": "1987", "meta_volume": "9 Suppl 3", "meta_issue": "", "meta_pages": "S99-107", "score": 50077.9, "text_hl": "@DISEASE_Hypotension @DISEASE_MESH:D007022 @@@Hypotension@@@, @<m>DISEASE_Headache</m> @DISEASE_MESH:D006261 @@@orthostatic effects@@@, or @DISEASE_Dizziness @DISEASE_MESH:D004244 @@@dizziness@@@ following the initial @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ dose occurred infrequently in @SPECIES_9606 @@@patients@@@ treated with @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@. ", "citations": {"NLM": "Rush JE, Merrill DD. The safety and tolerability of lisinopril in clinical trials. J Cardiovasc Pharmacol. 1987;9 Suppl 3():S99-107. PMID: 2442561", "BibTeX": "@article{2442561, title={The safety and tolerability of lisinopril in clinical trials.}, author={Rush JE and Merrill DD}, journal={J Cardiovasc Pharmacol}, volume={9 Suppl 3}, pages={S99-107}}"}}, {"_id": "2550641", "pmid": 2550641, "title": "Clinical experience with lisinopril. Observations on safety and tolerability.", "journal": "J Hum Hypertens", "authors": ["Cameron HA", "Higgins TJ"], "date": "1989-06-01T00:00:00Z", "meta_date_publication": "1989 Jun", "meta_volume": "3 Suppl 1", "meta_issue": "", "meta_pages": "177-86", "score": 50073.016, "text_hl": "In the @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ population, the most frequent adverse events reported were @<m>DISEASE_Headache</m> @DISEASE_MESH:D006261 @@@headache@@@, @DISEASE_Dizziness @DISEASE_MESH:D004244 @@@dizziness@@@, @DISEASE_Cough @DISEASE_MESH:D003371 @@@cough@@@, @DISEASE_Nausea @DISEASE_MESH:D009325 @@@nausea@@@, @DISEASE_Diarrhea @DISEASE_MESH:D003967 @@@diarrhoea@@@ and @DISEASE_Fatigue @DISEASE_MESH:D005221 @@@fatigue@@@, although not all of these events were thought to be related to @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@; 6.1% discontinued @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ due to adverse clinical events, most commonly @DISEASE_Cough @DISEASE_MESH:D003371 @@@cough@@@ and @DISEASE_Nausea @DISEASE_MESH:D009325 @@@nausea@@@. ", "citations": {"NLM": "Cameron HA, Higgins TJ. Clinical experience with lisinopril. Observations on safety and tolerability. J Hum Hypertens. 1989 Jun;3 Suppl 1():177-86. PMID: 2550641", "BibTeX": "@article{2550641, title={Clinical experience with lisinopril. Observations on safety and tolerability.}, author={Cameron HA and Higgins TJ}, journal={J Hum Hypertens}, volume={3 Suppl 1}, pages={177-86}}"}}, {"_id": "1665180", "pmid": 1665180, "title": "Review of international safety data for lisinopril-hydrochlorothiazide combination treatment.", "journal": "J Hum Hypertens", "authors": ["Murray NH"], "date": "1991-12-01T00:00:00Z", "meta_date_publication": "1991 Dec", "meta_volume": "5 Suppl 2", "meta_issue": "", "meta_pages": "63-7; discussion 68", "score": 50071.242, "text_hl": "In clinical trials, adverse experiences in @SPECIES_9606 @@@patients@@@ treated with a @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@-@CHEMICAL_Hydrochlorothiazide @CHEMICAL_MESH:D006852 @@@hydrochlorothiazide@@@ combination were @DISEASE_Dizziness @DISEASE_MESH:D004244 @@@dizziness@@@ (7.5%), @<m>DISEASE_Headache</m> @DISEASE_MESH:D006261 @@@headache@@@ (5.2%), @DISEASE_Cough @DISEASE_MESH:D003371 @@@cough@@@ (3.9%), @DISEASE_Fatigue @DISEASE_MESH:D005221 @@@fatigue@@@ (3.7%), @<m>DISEASE_Headache</m> @DISEASE_MESH:D006261 @@@orthostatic effects@@@ (3.2%), @DISEASE_Diarrhea @DISEASE_MESH:D003967 @@@diarrhoea@@@ (2.5%), @DISEASE_Nausea @DISEASE_MESH:D009325 @@@nausea@@@ (2.2%) and @DISEASE_Respiratory_Tract_Infections @DISEASE_MESH:D012141 @@@upper respiratory tract infection@@@ (2.2%). ", "citations": {"NLM": "Murray NH. Review of international safety data for lisinopril-hydrochlorothiazide combination treatment. J Hum Hypertens. 1991 Dec;5 Suppl 2():63-7; discussion 68. PMID: 1665180", "BibTeX": "@article{1665180, title={Review of international safety data for lisinopril-hydrochlorothiazide combination treatment.}, author={Murray NH}, journal={J Hum Hypertens}, volume={5 Suppl 2}, pages={63-7; discussion 68}}"}}, {"_id": "11141144", "pmid": 11141144, "title": "Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study.", "journal": "BMJ", "authors": ["Schrader H", "Stovner LJ", "Helde G", "Sand T", "Bovim G"], "date": "2001-01-06T00:00:00Z", "doi": "10.1136/bmj.322.7277.19", "meta_date_publication": "2001 Jan 6", "meta_volume": "322", "meta_issue": "7277", "meta_pages": "19-22", "score": 50064.83, "text_hl": "Thirty @SPECIES_9606 @@@participants@@@ followed this schedule, and 30 received placebo followed by @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@. MAIN OUTCOME MEASURES: Primary end points: number of hours with @<m>DISEASE_Headache</m> @DISEASE_MESH:D006261 @@@headache@@@, number of days with @<m>DISEASE_Headache</m> @DISEASE_MESH:D006261 @@@headache@@@, number of days with @DISEASE_Migraine_Disorders @DISEASE_MESH:D008881 @@@migraine@@@. ", "citations": {"NLM": "Schrader H, Stovner LJ, Helde G, Sand T, Bovim G. Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study. BMJ. 2001 Jan 6;322(7277):19-22. PMID: 11141144", "BibTeX": "@article{11141144, title={Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study.}, author={Schrader H and Stovner LJ and Helde G and Sand T and Bovim G}, journal={BMJ}, volume={322}, number={7277}, pages={19-22}}"}}, {"_id": "8390918", "pmid": 8390918, "title": "Lisinopril in the treatment of hypertension: a Canadian postmarketing surveillance study.", "journal": "Clin Ther", "authors": ["Huckell VF", "Bélanger LG", "Kazimirski M", "Subramanian T", "Cox AJ"], "date": "1993-03-01T00:00:00Z", "meta_date_publication": "1993 Mar-Apr", "meta_volume": "15", "meta_issue": "2", "meta_pages": "407-22", "score": 50062.86, "text_hl": "@<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@ was safe and well-tolerated. ", "citations": {"NLM": "Huckell VF, Bélanger LG, Kazimirski M, Subramanian T, Cox AJ. Lisinopril in the treatment of hypertension: a Canadian postmarketing surveillance study. Clin Ther. 1993 Mar-Apr;15(2):407-22. PMID: 8390918", "BibTeX": "@article{8390918, title={Lisinopril in the treatment of hypertension: a Canadian postmarketing surveillance study.}, author={Huckell VF and Bélanger LG and Kazimirski M and Subramanian T and Cox AJ}, journal={Clin Ther}, volume={15}, number={2}, pages={407-22}}"}}, {"_id": "10852646", "pmid": 10852646, "title": "Lisinopril: a review of its use in congestive heart failure.", "journal": "Drugs", "authors": ["Simpson K", "Jarvis B"], "date": "2000-05-01T00:00:00Z", "doi": "10.2165/00003495-200059050-00012", "meta_date_publication": "2000 May", "meta_volume": "59", "meta_issue": "5", "meta_pages": "1149-67", "score": 50062.523, "text_hl": "@<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@: a review of its use in @DISEASE_Heart_Failure @DISEASE_MESH:D006333 @@@congestive heart failure@@@.", "citations": {"NLM": "Simpson K, Jarvis B. Lisinopril: a review of its use in congestive heart failure. Drugs. 2000 May;59(5):1149-67. PMID: 10852646", "BibTeX": "@article{10852646, title={Lisinopril: a review of its use in congestive heart failure.}, author={Simpson K and Jarvis B}, journal={Drugs}, volume={59}, number={5}, pages={1149-67}}"}}, {"_id": "10676825", "pmid": 10676825, "title": "Syndrome of inappropriate antidiuretic hormone secretion associated with lisinopril.", "journal": "Ann Pharmacother", "authors": ["Shaikh ZH", "Taylor HC", "Maroo PV", "Llerena LA"], "date": "2000-02-01T00:00:00Z", "doi": "10.1345/aph.19116", "meta_date_publication": "2000 Feb", "meta_volume": "34", "meta_issue": "2", "meta_pages": "176-9", "score": 50061.78, "text_hl": "OBJECTIVE: To describe a case of the @DISEASE_Inappropriate_ADH_Syndrome @DISEASE_MESH:D007177 @@@syndrome of inappropriate antidiuretic hormone secretion@@@ (@DISEASE_Inappropriate_ADH_Syndrome @DISEASE_MESH:D007177 @@@SIADH@@@) associated with @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ therapy. CASE SUMMARY: A 76-year-old white @SPECIES_9606 @@@woman@@@ who was being treated with @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ and @CHEMICAL_Metoprolol @CHEMICAL_MESH:D008790 @@@metoprolol@@@ for @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ presented with @<m>DISEASE_Headache</m> @DISEASE_MESH:D006261 @@@headaches@@@ accompanied by @DISEASE_Nausea @DISEASE_MESH:D009325 @@@nausea@@@ and a @DISEASE_Paresthesia @DISEASE_MESH:D010292 @@@tingling sensation@@@ in her arms. ", "citations": {"NLM": "Shaikh ZH, Taylor HC, Maroo PV, Llerena LA. Syndrome of inappropriate antidiuretic hormone secretion associated with lisinopril. Ann Pharmacother. 2000 Feb;34(2):176-9. PMID: 10676825", "BibTeX": "@article{10676825, title={Syndrome of inappropriate antidiuretic hormone secretion associated with lisinopril.}, author={Shaikh ZH and Taylor HC and Maroo PV and Llerena LA}, journal={Ann Pharmacother}, volume={34}, number={2}, pages={176-9}}"}}, {"_id": "2442553", "pmid": 2442553, "title": "Evaluation of antihypertensive efficacy of lisinopril compared to metoprolol in moderate to severe hypertension.", "journal": "J Cardiovasc Pharmacol", "authors": ["Zachariah PK", "Bonnet G", "Chrysant SG", "DeBacker G", "Goldstein R", "Herrera J", "Lindner A", "Materson BJ", "Maxwell MH", "McMahon FG"], "date": "1987-01-01T00:00:00Z", "doi": "10.1097/00005344-198700003-00013", "meta_date_publication": "1987", "meta_volume": "9 Suppl 3", "meta_issue": "", "meta_pages": "S53-8", "score": 50056.75, "text_hl": "These decreases in systolic blood pressures were maintained at week 8, again with statistical significance (p less than 0.01). Of the 118 @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@-treated @SPECIES_9606 @@@patients@@@, four were discontinued from @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ therapy because of @<m>DISEASE_Headache</m> @DISEASE_MESH:D006261 @@@headache@@@, @DISEASE_Dizziness @DISEASE_MESH:D004244 @@@dizziness@@@, @DISEASE_Exanthema @DISEASE_MESH:D005076 @@@rash@@@, @DISEASE_Flushing @DISEASE_MESH:D005483 @@@flushing@@@, or @DISEASE_Lymphatic_Diseases @DISEASE_MESH:D008206 @@@lymphadenopathy@@@. ", "citations": {"NLM": "Zachariah PK, Bonnet G, Chrysant SG, DeBacker G, Goldstein R, Herrera J, Lindner A, Materson BJ, Maxwell MH, McMahon FG. Evaluation of antihypertensive efficacy of lisinopril compared to metoprolol in moderate to severe hypertension. J Cardiovasc Pharmacol. 1987;9 Suppl 3():S53-8. PMID: 2442553", "BibTeX": "@article{2442553, title={Evaluation of antihypertensive efficacy of lisinopril compared to metoprolol in moderate to severe hypertension.}, author={Zachariah PK and Bonnet G and Chrysant SG and DeBacker G and Goldstein R and Herrera J and Lindner A and Materson BJ and Maxwell MH and McMahon FG}, journal={J Cardiovasc Pharmacol}, volume={9 Suppl 3}, pages={S53-8}}"}}, {"_id": "9358963", "pmid": 9358963, "title": "Nisoldipine CC and lisinopril alone or in combination for treatment of mild to moderate systemic hypertension. Canadian Nisoldipine CC Hypertension Trial Group.", "journal": "Cardiovasc Drugs Ther", "authors": ["Ruddy TD", "Fodor JG"], "date": "1997-09-01T00:00:00Z", "doi": "10.1023/a:1007744005480", "meta_date_publication": "1997 Sep", "meta_volume": "11", "meta_issue": "4", "meta_pages": "581-90", "score": 50054.984, "text_hl": "Adverse effects were more frequent with nisoldipine CC (@<m>DISEASE_Headache</m> @DISEASE_MESH:D006261 @@@headache@@@ and @DISEASE_Edema @DISEASE_MESH:D004487 @@@peripheral edema@@@) than with @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ (@DISEASE_Cough @DISEASE_MESH:D003371 @@@cough@@@) monotherapy. ", "citations": {"NLM": "Ruddy TD, Fodor JG. Nisoldipine CC and lisinopril alone or in combination for treatment of mild to moderate systemic hypertension. Canadian Nisoldipine CC Hypertension Trial Group. Cardiovasc Drugs Ther. 1997 Sep;11(4):581-90. PMID: 9358963", "BibTeX": "@article{9358963, title={Nisoldipine CC and lisinopril alone or in combination for treatment of mild to moderate systemic hypertension. Canadian Nisoldipine CC Hypertension Trial Group.}, author={Ruddy TD and Fodor JG}, journal={Cardiovasc Drugs Ther}, volume={11}, number={4}, pages={581-90}}"}}, {"_id": "1330386", "pmid": 1330386, "title": "Efficacy and tolerability of lisinopril compared with extended release felodipine in patients with essential hypertension. Danish Cooperative Study Group.", "journal": "Clin Exp Hypertens A", "authors": ["Jensen HA"], "date": "1992-01-01T00:00:00Z", "doi": "10.3109/10641969209038195", "meta_date_publication": "1992", "meta_volume": "14", "meta_issue": "6", "meta_pages": "1095-110", "score": 50052.95, "text_hl": "On @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ treatment, reports of @<m>DISEASE_Headache</m> @DISEASE_MESH:D006261 @@@headache@@@ and @DISEASE_Dizziness @DISEASE_MESH:D004244 @@@dizziness@@@ were reduced while that of @DISEASE_Cough @DISEASE_MESH:D003371 @@@cough@@@ increased. ", "citations": {"NLM": "Jensen HA. Efficacy and tolerability of lisinopril compared with extended release felodipine in patients with essential hypertension. Danish Cooperative Study Group. Clin Exp Hypertens A. 1992;14(6):1095-110. PMID: 1330386", "BibTeX": "@article{1330386, title={Efficacy and tolerability of lisinopril compared with extended release felodipine in patients with essential hypertension. Danish Cooperative Study Group.}, author={Jensen HA}, journal={Clin Exp Hypertens A}, volume={14}, number={6}, pages={1095-110}}"}}]}